SAKAR1,120.00

Sakar Healthcare Limited

· Unclassified
₹ CrorePeersMACPOWERSERVOTECHKAPSTONTHEJOBETAMcap ₹2,492 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SAKAR
FY26
BLEL
no data
MVELECTRO
no data
MACPOWER
FY26
Peer
Median
Valuation — at last close
P/E81.75×55.14×55.14× +48%
P/B7.68×10.66×10.66× -28%
EV/EBITDA36.25×34.50×34.50× +5%
Market Cap₹2,492 Cr₹1,868 Cr₹1,868 Cr +33%
Growth
Revenue CAGR 3Y23.59%18.17%18.17% +30%
Revenue CAGR 5Y21.59%24.17%24.17% -11%
Net Income CAGR 3Y33.69%37.99%37.99% -11%
Revenue YoY (latest Q)38.37%56.06%56.06% -32%
Net Income YoY (latest Q)120.17%110.33%110.33% +9%
Profitability
EBITDA Margin27.37%16.20%16.20% +69%
Net Income Margin12.11%10.17%10.17% +19%
Return on Common Equity9.40%19.33%19.33% -51%
Return on Capital Employed12.20%26.09%26.09% -53%
Return on Assets6.34%12.76%12.76% -50%
Credit & Quality
Total Debt/Equity0.17×0.00×0.00×
Interest Coverage5.77×29.74×29.74× -81%
Scale — latest FY
Revenue / Total Income₹252 Cr₹333 Cr₹333 Cr -24%
Net Income₹30.5 Cr₹33.9 Cr₹33.9 Cr -10%
Total Assets₹481 Cr₹265 Cr₹265 Cr +81%
EPS₹13.7₹33.86₹33.86 -60%
Book Value per Share₹145.82₹175.17₹175.17 -17%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.